Thermoradiotherapy planning: Integration in routine clinical practice. (2nd January 2016)

• Record Type: Journal Article
• Authors: Crezee, Hans; van Leeuwen, Caspar M.; Oei, Arlene L.; Stalpers, Lukas J.A.; Bel, Arjan; Franken, Nicolaas A.; Kok, H. Petra
• Is Part Of: International journal of hyperthermia. Volume 32:Number 1(2016)
• Page Start: 41
• Page End: 49
• Publication Date: 2016-01-02
• Subjects: Hyperthermia -- linear-quadratic model -- radiotherapy -- TER -- treatment planning; Thermotherapy -- Periodicals; 615.832
• DOI: 10.3109/02656736.2015.1110757
• Languages: English
• ISSNs: 0265-6736

Abstract

Abstract: Planning of combined radiotherapy and hyperthermia treatments should be performed taking the synergistic action between the two modalities into account. This work evaluates the available experimental data on cytotoxicity of combined radiotherapy and hyperthermia treatment and the requirements for integration of hyperthermia and radiotherapy treatment planning into a single planning platform. The underlying synergistic mechanisms of hyperthermia include inhibiting DNA repair, selective killing of radioresistant hypoxic tumour tissue and increased radiosensitivity by enhanced tissue perfusion. Each of these mechanisms displays different dose-effect relations, different optimal time intervals and different optimal sequences between radiotherapy and hyperthermia. Radiosensitisation can be modelled using the linear-quadratic (LQ) model to account for DNA repair inhibition by hyperthermia. In a recent study, an LQ model-based thermoradiotherapy planning (TRTP) system was used to demonstrate that dose escalation by hyperthermia is equivalent to ∼10 Gy for prostate cancer patients treated with radiotherapy. The first step for more reliable TRTP is further expansion of the data set of LQ parameters for normally oxygenated normal and tumour tissue valid over the temperature range used clinically and for the relevant time intervals between radiotherapy and hyperthermia. The next step is to model the effect of hyperthermia in hypoxic tumour cells including the physiological response to hyperthermia and the resulting reoxygenation. Thermoradiotherapy planning is feasible and a necessity for an optimal clinical application of hyperthermia combined with radiotherapy in individual patients.